Peter Groitl
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53.
Journal: Journal of virology
Published: March 07, 2024
SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.
Journal: Microbiology spectrum
Published: May 18, 2023
PML Alternative Splice Products Differentially Regulate HAdV Productive Infection.
Journal: Microbiology spectrum
Published: June 14, 2022
ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 13, 2019
The human adenovirus type 5 E1B 55kDa protein interacts with RNA promoting timely DNA replication and viral late mRNA metabolism.
Journal: PloS one
Published: December 26, 2018
Adenovirus replaces mitotic checkpoint controls.
Journal: Journal of virology
Published: January 26, 2015
Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis.
Journal: Biochimie
Published: January 18, 2015
PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53.
Journal: Oncogene
Published: July 30, 2014
Sp100 isoform-specific regulation of human adenovirus 5 gene expression.
Journal: Journal of virology
Published: March 14, 2014
Last Updated: 09/26/2026